Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome

NCT05330845 is registered in ClinicalTrials.gov with Centre Hospitalier Henri Duffaut - Avignon as lead sponsor.

NCT NCT05330845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
Lead sponsor
Centre Hospitalier Henri Duffaut - Avignon
Phase
Not applicable
Overall status
Terminated
Start date
August 5, 2021
Completion date
December 31, 2022
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome